Category Archives: Depakote

Featured Stories
Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Depakote Anti-Epilepsy Medication Linked to Birth Defects

Depakote Anti-Epilepsy Medication Linked to Birth Defects

The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged , , , , |

$15 Million in Damages Awarded to Child for Birth Defects Linked to Depakote

$15M Awarded to Child for Defects Linked to Depakote

This week a St. Louis jury found that a Minnesota girl’s birth defects were caused by the epilepsy medication Depakote her mother took during pregnancy and the jury awarded the child $15 million in damages. The jury returned the unanimous … Continue reading

Posted in Birth Defects, Depakote, Legal News, Pharmaceuticals | Tagged , , , , |

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

British Health Agency Strengthens Warnings about Valproate

The Medicines and Healthcare Products Regulatory Agency (MHRA), Britain’s drug regulatory agency, has issued a statement urging healthcare professionals to give women better information on the risk of birth defects when Depakote and other valproate medicines are used during pregnancy. … Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Epilepsy Medications Tied to Additional Fetal Risks

epilepsy_medications_fetal_risks

An emerging study has found that anti-epileptic drugs—AEDs—contain additional risks to developing fetuses to those on current drug product labeling. AEDs include the brands Tegretol, Carbatrol, Equetro, Epitol, Lomotrigine, and Depakote. The active ingredient in Depakote is valproate. The Danish … Continue reading

Posted in Depakote, Pharmaceuticals |

Study: Reducing Valproate Dose Could Help Minimize Some, Not All, Birth Defects

valporate_specific_birth_defects

Valproate-containing epilepsy drugs have long been linked to serious adverse health effects, including risks of babies being born with birth defects. Depakote is a valproate-containing medication. For instance, while use of epilepsy medications during pregnancy has been associated with congenital … Continue reading

Posted in Depakote, Pharmaceuticals |

Abbott Labs Accused of Racketeering in Depakote Marketing

abbott_acused_of_racketeering

A federal court complaint filed in U.S. District Court in Chicago alleges that Abbott Laboratories engaged in racketeering when it marketed the epilepsy drug Depakote (divalproex) for unapproved uses. The plaintiffs—the Sidney Hillman Health Center of Rochester, New York; the … Continue reading

Posted in Depakote, Pharmaceuticals |

Judge Rules Abbott Can be Sued for Off-label Depakote Sales

Depakote_Off_Label_Sales

U.S. District Judge Virginia Kendall recently upheld a shareholder derivative complaint against Abbott Laboratories for its off-label marketing of the drug Depakote. Physicians are allowed to prescribe drugs for off-label uses, but drug companies are not permitted to market drugs … Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Legal News, Pharmaceuticals |

FDA: Migraine Medication, Depakote, May Lower IQ Scores in Children

Depakote_Lower_IQ

United States regulators are warning pregnant women who also suffer from migraine headaches that Depakote may lower a child’s IQ score by eight to 11 points. Depakote is being changed from a Category D to a Category X drug classification. … Continue reading

Posted in Depakote, Pharmaceuticals |

FDA Warns Pregnant Women: Do Not Take Valproate Containing Migraine Prevention Drugs During Pregnancy

Valproate_Pregnancy_FDA-Warning

The U.S. Food and Drug Administration (FDA) has issued a warning to pregnant women against using valproate sodium products, prescribed for migraine prevention, over risks to their unborn babies. Valproate products include Depacon (valproate sodium); Depakote, Depakote CP, and Depakote … Continue reading

Posted in Depakote, Pharmaceuticals |

FDA: Seizure Drug, Potiga, Associated with Vision Loss, Blue Skin

Anti-seizure medication, Potiga, co-marketed by GlaxoSmithKline Plc and Valeant Pharmaceuticals, may lead to optical and skin problems, the U.S. Food and Drug Administration (FDA) has said. Potiga, which was developed by Valeant, may cause skin to turn blue around the … Continue reading

Posted in Depakote, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.